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A B S T R A C T
The 20,50 (OASs) are known as mediators of the antiviral response system through activation of the RNA
cleavage pathway. Interestingly, we observe OAS1, OAS2 and OAS3 upregulation in a number of gene
expression signatures which discriminate active TB from latent TB infection, however their biological role
during bacterial infection has not yet been elucidated. We observed that the expression of these genes
was associated with pathogenicity and virulence of mycobacteria as infection with Mycobacterium bovis
BCG failed to significantly induce OAS expression. Further, we observed that after silencing of these genes,
M. tb CFU counts increased significantly 96 h post-infection in comparison to the respective controls.
Luminex revealed that OAS silencing significantly decreased IL-1β, TNF-α and MCP-1 and had no effect of
IL-10 secretion. We show for the first time that OAS1, 2 and 3 restrict intracellular pathogenic
mycobacterial replication and enhance pro-inflammatory cytokine secretion.
© 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Recent evidence suggests largely unifying pathways with regards
to sensing and responding to bacterial and viral pathogens. One such
pathway is the type I IFN-inducing pathway which is crucial during
viral clearance, but detrimental during bacterial infections (Decker
et al., 2005), particularly mycobacterial infections (Manca et al.,
2001; McNab et al., 2015). During either infection, IFNαβ release
induces the transcription of several hundred IFN-stimulated-genes
(ISGs) (Ezelle et al., 2016). Amongst these ISGs is the 20-50-
oligoadenylate synthetases (OAS) gene family.
To date the 20-50-oligoadenylate synthetases (OAS), namely
OAS1, OAS2 and OAS3 are known for their role in directly
enhancing intracellular antiviral mechanisms. Their expression
is induced following the release of type I interferons, where they
function to polymerize ATP to 20-50-linked adenosine oligomers or
2-5A (pppA(20p50A)n) in the presence of dsRNA (viral origin)
(Kristiansen et al., 2010). The 2–5As then activate the RNase L
degradative pathway which functions to cleave the viral RNA and
control the infection. Since the OASs are a product of the type I IFN
response, it is expected that they may play a role during bacterial* Corresponding author.
E-mail address: ginal@sun.ac.za (G. Leisching).
https://doi.org/10.1016/j.ijid.2019.02.029
1201-9712/© 2019 The Authors. Published by Elsevier Ltd on behalf of International Soc
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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OAS1, OAS2 and OAS3 upregulation has been observed in a number
of gene expressions signatures which discriminate active from
latent tuberculosis (Berry et al., 2010; Maertzdorf et al., 2012;
Ottenhoff et al., 2012). It is known that the activation of all 3 OASs
in the absence of viral nucleic acids cleave and degrade host mRNA
through RNaseL, which slows down protein synthesis and induces
apoptosis (Castelli et al., 1998b), and recently, it was suggested that
OAS1 and OAS2 are likely to have alternative roles (Li et al., 2016).
It is unknown whether the expression of the OASs plays a
similar role during bacterial infection through enhancing anti-
bacterial mechanisms. Here, we characterise OAS1, OAS2 and OAS3
expression in macrophages during mycobacterial infection by i)
determining whether their expression is linked to pathogenicity
and/or virulence of mycobacteria, ii) assessing the biological role of
OAS1, OAS2 and OAS3 during the infection of macrophages through
silencing of each of the genes, and iii) analysing whether OAS
silencing affects cytokine and chemokine secretion during infec-
tion. Our results reveal for the first time that OAS1, OAS2 and OAS3
restrict intracellular mycobacterial growth, and through an
unknown mechanism, appear to enhance cytokine/chemokine
secretion. This study suggests that the OASs may assist in priming
host-defence mechanisms for both viral and mycobacterial
infections and broadens the existing knowledge on host defence
mechanisms of the human macrophage.iety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
ersity from ClinicalKey.com by Elsevier on October 21, 
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OAS1, OAS2 and OAS3 expression in infected THP-1 cells is associated
with mycobacterial pathogenicity and virulence
We first set out to determine whether the expression of OAS1,
OAS2 and OAS3 was associated with mycobacterial pathogenicity
and/or virulence through qPCR and immunofluorescence techni-
ques (Figure 1). Interestingly, OAS1, OAS2 and OAS3 expression was
significantly induced 24 h post-infection by the virulent R5527 M.
tb strain only (Figure 1A), however immunofluorescence indicates
that both the hypo- and hypervirulent M. tb strains induce
significant expression of the protein components of these genes
(Figure 1B). Conversely, Mycobacterium bovis BCG infection did not
stimulate expression of these genes or their proteins 24 h p.i. This
data therefore suggests that in infected THP-1 cells, OAS1, OAS2 and
OAS3 expression is dependent on the pathogenicity and virulence
of the mycobacterial strain early post-infection.
Silencing of OAS1, OAS2 and OAS3 promotes intracellular
mycobacterial replication
To determine whether the absence of these genes affected
intracellular mycobacterial replication, each gene was silenced
separately and confirmed through qPCR and Western blot (Figure
S1) using two siRNAs coding different target sequences (Figure 2).
Additionally, the infection time was extended to 96 h to observe
whether changes in the standard doubling times of the mycobac-
teria were affected. Further, host cell viability was assessedFigure 1. OAS1, 2 and 3 expression in THP-1 cells following infection with M. bovis BCG, R
2 and 3 expression 24 h post-infection. UBC and GAPDH were used as reference genes to c
with OAS1, OAS2 or OAS3 primary antibody and then stained with a Texas Red secondary a
a LSM 780 Elyra S1 Confocal laser-scanning microscope, with a 63X, 1,4NA, oil-immersion
of 12 images acquired in each experimental condition, carried out in triplicate. Scale bar =
vs. uninfected.
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gene silencing affected host cell survival during infection. Finally, a
negative siRNA control was included in all experiments to control
for the silencing procedure. In these experiments, we included
silencing of all 3 OASs at once, as well as in different combinations
to determine whether the measured parameters were affected to a
greater extent, however no significant differences were observed
(data not shown). Figure 2A depicts intracellular CFU counts and
host-cell viability during OAS1 silencing in THP-1s infected with
either the pathogenic or non-pathogenic mycobacterial strains.
After 24 h, a slight decrease in CFU counts was observed in M. bovis
BCG and hypovirulent M. tb infected THP-1 cells in the infected
(denoted M. bovis BCG and R1507 respectively) and negative
control groups (denoted as ‘scr. sequence’). Conversely, this
decrease in CFU counts was not observed during infection with
the hypervirulent strain (R5527) which illustrates the virulent
phenotype of this strain. After silencing with both OAS1 siRNA #1
and #2, little to no significant differences were observed at the 24 h
time point, however after 96 h, significant increases in intracellular
CFU counts were observed with all strains when comparing the
infection without silencing and the negative silencing control
(Figure 2A). Further, no significant differences in host cell viability
were observed over the 96 h time period. As with OAS1, silencing of
OAS2 exhibited similar results for the pathogenic mycobacteria
(Figure 2B), however downregulation of OAS2 expression during
infection did not affect the intracellular replication of M. bovis BCG.
Both pathogenic and non-pathogenic mycobacterial CFUs in-
creased significantly 96 h p.i after silencing of OAS3 (Figure 2C)
with no significant differences in host cell viability observed. This1507 M. tb (hypovirulent) and R5527 M. tb (hypervirulent). A. qPCR analysis of OAS1,
alculate the relative expression of the target genes. B. THP-1s were immunostained
ntibody. Nuclei were counter-stained with Hoechst (blue). Images were acquired on
 objective. Average fluorescent intensity was quantified using Image J of the analysis
 20 mM. ANOVA with a Bonferroni post-hoc test was applied, **p < 0.01, ***p < 0.001
versity from ClinicalKey.com by Elsevier on October 21, 
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Figure 2. Intracellular growth of pathogenic and non-pathogenic mycobacteria and THP-1 viability after silencing of either OAS1, 2 or 3 over a 96 h time period. Two siRNA
molecules (siRNA #1 and siRNA #2) with different targets were used for each gene, as well as scrambled sequence (negative control) A. OAS1 silencing did not affect host-cell
viability but significantly increased the intracellular CFU counts of all strains 96 h p.i. B. Silencing of OAS2 had no effect on the intracellular growth of M. bovis BCG, however
both pathogenic strains had significant increases in their intracellular CFUs 96 h p.i. Host cell viability was not affected by OAS2 silencing. C. Intracellular CFU counts increased
significantly 96 h p.i for both pathogenic and non-pathogenic strains after OAS3 silencing. No significant effects on THP-1 viability was observed. Two-way ANOVA with a
Bonferroni post-hoc test was applied, **p < 0.01, ***p < 0.001 vs. infected unsilenced and infected silenced (scrambled sequence).
G. Leisching et al. / International Journal of Infectious Diseases 80 (2019) S77–S84 S79data suggests that when expressed following infection, OAS1, 2 and
3 function to suppress the intracellular replicative capacity of
mycobacteria and suggests an antibacterial, host-defence function,
which up until now, was previously unknown.
Silencing of OAS1, OAS2 and OAS3 affects cytokine and chemokine
expression in THP-1 cells during mycobacterial infection
Mycobacterial infection and replication is controlled through
the release of cytokines and chemokines as part of the innate
immune response to pathogen invasion. Since the mechanism by
which the genes restrain intracellular mycobacterial replication is
unknown, and given the fact that OAS1, OAS2 and OAS3 are
interferon-induced genes, we sought to determine whether
silencing affected cytokine/chemokine expression using Luminex1
technology.
Firstly we silenced OAS1 and noted that TNF-α release was
significantly reduced at both 24 and 96 h p.i after infection with both
pathogenic and non-pathogenic mycobacteria in comparison to the
unsilenced infected control and the infected scrambled sequence
control (Figure 3A). Similarly, IL-1β release was significantly reduced
during infectionwith all strains, but onlyat 96 h p.i (Figure 3B). In our
model, IL-10 levels were only detectable 96 h p.i by Luminex and we
observed that IL-10 release was unaffected by the silencing of OAS1
(Figure 3C). The analysis of MCP-1 (CCL2) indicated that OAS1
silencing during M. bovis BCG infection had no effect on MCP-1
release, however MCP-1 levels were significantly reduced 96 h p.i
during infection with both pathogenic mycobacteria (Figure 3D).
This data suggests that i) TNF-α and IL-1β secretion is enhanced
during mycobacterial infection in the presence of OAS1, ii) IL-10
production is unaffected by the presence/absence of OAS1, and iii)Downloaded for Anonymous User (n/a) at Stellenbosch Univer
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pathogenic mycobacteria only.
Secondly we silenced OAS2 to determine whether its presence
affects cytokine production during infection (Figure 4). In
comparison to the unsilenced infected control and the infected
scrambled sequence control, TNF-α and IL-1β levels were
significantly reduced following OAS2 silencing during infection
with hypovirulent (24 and 96 h p.i) and hypervirulent (96 h p.i)
pathogenic mycobacteria only (Figure 4A and B). IL-10 levels
remain unchanged in response to OAS2 silencing (Figure 4C), and
MCP-1 secretion was observed to be unaffected in THP-1s infected
with pathogenic mycobacteria (Figure 4D). Interestingly, non-
pathogenic mycobacterial infection in the absence of OAS2
enhanced MCP-1 secretion. Together these results suggest that i)
TNF-α and IL-1β secretion is enhanced during pathogenic M. tb
infection in the presence of OAS2, ii) IL-10 secretion remains
unaffected by OAS2, and iii) MCP-2 is unaffected by OAS2 during
pathogenic M. tb infection.
Lastly we assessed whether OAS3 affected cytokine secretion
during mycobacterial infection (Figure 5). TNF-α levels decreased
significantly after OAS3 silencing in response to infection with
pathogenic mycobacteria and remain unchanged in response to
non-pathogenic mycobacterial infection (Figure 5A). IL-1β levels
were also reduced following silencing, however this was observed
during infection with all mycobacterial strains (Figure 5B). As with
OAS1 and OAS2, IL-10 secretion was not affected by OAS3 silencing
(Figure 5C), and MCP-1 secretion was only affected by infection
with pathogenic mycobacteria only.
The effects of OAS1, 2 and 3 on cytokine secretion during
infection with pathogenic and non-pathogenic mycobacteria in
THP-1 macrophages may be summarised as follows: TNF-α and IL-sity from ClinicalKey.com by Elsevier on October 21, 
. Copyright ©2021. Elsevier Inc. All rights reserved.
Figure 3. The effect of OAS1 silencing on TNF-α, IL1-β, IL-10 and MCP-1 secretion in THP-1 cells infected with pathogenic and non-pathogenic mycobacteria as measured by
Luminex. Two siRNA molecules (siRNA #1 and siRNA #2) with different targets were used for OAS1, as well as scrambled sequence (Sc. siRNA-negative control) A. TNF-α
secretion decreased significantly at both 24 and 96 h p.i after OAS1 silencing in both pathogenic and non-pathogenic infection states. B. Significant differences in IL-1β
secretion were only observed 96 h p.i with pathogenic and non-pathogenic mycobacteria. C. Silencing of OAS1 did not affect IL-10 secretion. D. MCP-1 decreased significantly
96 h p.i with pathogenic mycobacteria only. ANOVA with a Bonferroni post-hoc test was applied, **p < 0.01, ***p < 0.001 vs. uninfected.
S80 G. Leisching et al. / International Journal of Infectious Diseases 80 (2019) S77–S841β secretion are enhanced by OAS1, 2 and 3 during M. tb infection.
IL-10 secretion is not dependent on/associated with the presence
of the OAS proteins and MCP-1 secretion is enhanced by OAS1 and
3, but not OAS2 during M. tb infection.
Discussion
The20,50 oligoadenylatesynthetases(OASs)havebeendocumented
as playing a role in the antiviral innate immune response during
infection and function to produce 2–5A activators of the RNaseL
cleavage pathway which ultimately lead to the control of the viral
infection (Castelli et al., 1998a; Lohöfener et al., 2015; Li et al., 2016).
OAS1, OAS2 and OAS3 are expressed as a result of IFNαβ and thus form
part of the interferon stimulated genes (ISGs) that are associated
with the early inflammatory response during infection and are
evolutionarily conserved (Justesen et al., 2000; Yao et al., 2018).
Transcriptomics of patients with active tuberculosis reveal the
upregulation of OAS1, OAS2 and OAS3, which all form part of the TB
signature that discriminates active from latent tuberculosis and
other diseases (Berry et al., 2010; Maertzdorf et al., 2011; Ottenhoff
et al., 2012). This suggests that these genes may play a role during
activemycobacterial infection (Leischingetal.,2018),although this is
yet to be determined. To answer this question we aimed to
characterise the role of these genes in response to pathogenic and
non-pathogenic mycobacterial infection and to determine whether
their presence affects intracellular mycobacterial survival. Therefore
we sought to elucidate whether the OASs play a role in restricting
microbial growth during infection. Characterisation of their
biological role included i) the analysis of the genes/proteins in
response to non-pathogenic and virulent mycobacterial infection, ii)
silencing of the genes to determine whether their downregulationDownloaded for Anonymous User (n/a) at Stellenbosch Uni
2021. For personal use only. No other uses without permisduring infection affected intracellular mycobacterial growth over
time, and finally iii) since these genes are induced by IFN αβ, whether
silencing of OAS1, 2 and 3 affected cytokine expression inTHP-1 cells.
We included the use of the non-pathogenic M. bovis BCG strain, as
well as a hypovirulent (R1507) and hypervirulent (R5527)
Mycobacterium tuberculosis strain to determine whether pathoge-
nicity and/or virulence affects the expression of OAS1, OAS2 and
OAS3 (Figure 1A and B). We observed that OAS expression is directly
related to Mycobacterial pathogenicity early post-infection. It
cannot be discounted that infection with M. bovis BCG does not
induce OAS expression at all. It is possible that non-pathogenic
strains induce the OASs, but at a later time point post-infection. This
early response by infection with pathogenic mycobacteria may be
explained by the following: After phagocytosis, most pathogenic
intracellular bacteria mediate the phagosome breach which leads to
content leakage in the form of dsDNA into the host cytoplasm
(Vance et al., 2009; Manzanillo et al., 2012). The ESX-1 secretion
system in pathogenic mycobacteria facilitate the perforation of the
phagosome (Manzanillo et al., 2012), which leads to the release of
extracellular mycobacterial DNA into the host cytosol. The OASs are
activated by double stranded nucleic acids (Lohöfener et al., 2015)
and are therefore nucleic acid sensors. OAS1 specifically, is
structurally homologous to cGAS, the dsDNA sensor (Chen et al.,
2016), which when activated, leads to the downstream activation of
STING. STING is an essential molecule type I IFN transcription in the
presence of foreign nucleic acids (Ishikawa et al., 2009), which then
induces OAS1, 2 and 3 transcription as part of the ISGs. This may
explain the early response of the OASs following infection with the
pathogenic strains only.
It is known that cytokines play an important role in controlling
mycobacterial infection without promoting uncontrolled andversity from ClinicalKey.com by Elsevier on October 21, 
sion. Copyright ©2021. Elsevier Inc. All rights reserved.
Figure 4. The effect of OAS2 silencing on TNF-α, IL1-β, IL-10 and MCP-1 secretion in THP-1 cells infected with pathogenic and non-pathogenic mycobacteria as measured by
Luminex. Two siRNA molecules (siRNA #1 and siRNA #2) with different targets were used for OAS2, as well as scrambled sequence (Sc. siRNA-negative control) A. TNF-α
secretion decreased significantly 96 h p.i after OAS2 silencing in both pathogenic infection states. B. Significant differences in IL-1β secretion were only observed 96 h p.i after
infection with pathogenic mycobacteria only. C. Silencing of OAS2 did not affect IL-10 secretion. D. No effect on MCP-1 secretion was observed during pathogenic
mycobacterial infection. ANOVA with a Bonferroni post-hoc test was applied, **p < 0.01, ***p < 0.001 vs. uninfected.
G. Leisching et al. / International Journal of Infectious Diseases 80 (2019) S77–S84 S81damaging inflammatory responses. Since the OASs are induced
following the onset of the inflammatory response, we investigated
whether the downregulation of OAS1, OAS2 and OAS3 affected the
intracellular replicative capacity of mycobacteria (Figure 2) and
whether the expression of various cytokines were affected
(Figures 3–5) as a possible explanation for the unrestricted
growth. We observed that at 96 h, both the pathogenic and non-
pathogenic mycobacterial CFUs increased significantly when
compared to the infected unsilenced and infected silenced control
when OAS1, 2 and 3 were silenced. During viral infection, OAS1,
OAS2 and OAS3 knock-down also promotes the intracellular
replication of a number of RNA and DNA viruses (Melchjorsen
et al., 2009; Zhao et al., 2012; Wang et al., 2013; Li et al., 2016),
which taken together, points to an anti-microbial, rather than just
an anti-viral function of these proteins. Interestingly, IL-1β and
TNF-α secretion levels are both significantly reduced at this time
point post-OAS silencing during infection with both the pathogenic
strains in particular. Recently, both IL-1β and TNF-α were described
as hallmark cytokines of the innate immune response that
contribute to “trained immunity” by macrophages that are
essential in controlling mycobacterial growth (Kleinnijenhuis
et al., 2014). To date however, there is no work investigating
whether the OASs affect the secretion of these cytokines
specifically, however the OASs have been documented to enhance
IL-12A (Domingo-Gil et al., 2010) and IL-17A (Wang et al., 2013)
during viral infection. It is therefore likely that their presence
modulates the activation of other signalling pathways responsible
for cytokine production.
Further, we observed that OAS2 silencing did not affect MCP-1
secretion (Figure 4D), but OAS1 (Figure 3D) and 3 silencingDownloaded for Anonymous User (n/a) at Stellenbosch Univer
2021. For personal use only. No other uses without permission(Figure 5D) significantly reduced MCP-1 levels. Additionally,
intracellular M. bovis BCG growth was not significantly affected
when OAS2 was silenced (Figure 2B). Studies assessing the anti-
viral roles of the OASs revealed that OAS2 was unable to block
Dengue virus (Lin et al., 2009) and hepatitis C virus (Kwon et al.,
2013) replication, however this does not explain why OAS2
silencing led to enhanced intracellular replication of M. tb in our
model. Also, the reason as to why OAS2 does not affect MCP-1
secretion, but affects IL-1β and TNF-α which are all transcribed
through NF-kB, is challenging to explain. Two OAS2 isoforms (p69
and p71) exist (Justesen et al., 2000), although very little is known
regarding the individual functions of each isoform. It has been
proposed recently that since OAS2 is a weak activator of RNaseL in
comparison to OAS1 and OAS3, alternative roles for this protein are
likely to exist (Li et al., 2016). Therefore OAS2 may function
primarily during pathogenic mycobacterial infection, although its
precise role, which should include analysis of both isoforms,
should be assessed.
IL-10 is a potent anti-inflammatory and immunosuppressive
molecule and functions to inhibit a range of pro-inflammatory
cytokines such as TNF-α, IL-1, IL-6, and IL-12 (D'andrea et al., 1993;
Moore et al., 2001). It was interesting to note that silencing of the
OASs had no effect on IL-10 secretion (Figures 3D, 4D and 5D). This
could be explained by the fact that, 1) unlike other cytokines,
expression of IL10 is regulated by the Sp1 and Sp3 transcription
factors that are constitutively and ubiquitously expressed (Tone
et al., 2000) and function under different elements of regulatory
control when compared to the proinflammatory cytokines, and 2)
that OASs expression may directly or indirectly suppress IL-10
secretion through unknown mechanisms.sity from ClinicalKey.com by Elsevier on October 21, 
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Figure 5. The effect of OAS3 silencing on TNF-α, IL1-β, IL-10 and MCP-1 secretion in THP-1 cells infected with pathogenic and non-pathogenic mycobacteria as measured by
Luminex. Two siRNA molecules (siRNA #1 and siRNA #2) with different targets were used for OAS3, as well as scrambled sequence (Sc. siRNA-negative control) A. TNF-α
secretion decreased significantly 96 h p.i after OAS3 silencing in the pathogenic infection state only. B. Significant differences in IL-1β secretion were observed at 96 h p.i after
infection with pathogenic and non-pathogenic mycobacteria only. C. Silencing of OAS2 did not affect IL-10 secretion. D. MCP-1 secretion decreased significantly following
OAS3 silencing, but was observed during pathogenic mycobacterial infection only. ANOVA with a Bonferroni post-hoc test was applied, *p < 0.05, **p < 0.01, ***p < 0.001 vs.
uninfected.
Table 1
Target sequences of siRNAs specific to OAS1, OAS2 and OAS3.




S82 G. Leisching et al. / International Journal of Infectious Diseases 80 (2019) S77–S84Although the OASs are overexpressed following infection, it may be
advantageous to test whether a similar result is observed through a
vector-based overexpression system. Additionally, future studies
should demonstrate if the induction and function of OAS is dependent
ontypeIIFNsandwhethertheblockadeoftypeIIFNsignalingincreases
or decreases bacterial loads. Since IL-1β and TNF-α are most greatly
affected by OASs knock-down, neutralisation of these two cytokines
should greatly affect M. tb intracellular replication. Although our
study does not uncover the mechanism by which the OASs enhance
cytokine secretion during mycobacterial infection, it does uncover
for the first time that OAS1, 2 and 3 restrict mycobacterial
intracellular replication. Thus the OASs may no longer be associated
with enhancing antiviral responses only, but also show an
involvement with antimicrobial responses in the macrophage.
Experimental procedures
Cell culture
THP-1 (ATCC-88081201) human macrophage-like cells were
cultured in RPMI-1640 supplemented with 10% heat-inactivated
foetal calf serum (Biochrome, Germany) and incubated at 37 C, 5%
CO2. For infection experiments, THP-1 cells were differentiated
into macrophage-like cells with Phorbol 12-Myristate 13-Acetate
(PMA; Sigma Aldrich, USA) at a final concentration of 100 nM for
24 h prior to infection.
Bacterial strains and infection conditions
M. bovis BCG as well as hyper (R5527) and hypovirulent (R1507)
Beijing M. tuberculosis clinical isolates (Aguilar et al., 2010) wereDownloaded for Anonymous User (n/a) at Stellenbosch Uni
2021. For personal use only. No other uses without permisused for infection. Mycobacteria were cultured in 7H9 (supple-
mented with 10% OADC, 0.5% glycerol) without Tween 80
(Leisching et al., 2016a,b). THP-1s were infected with either the
hyper-, hypovirulent M. tb or M. bovis BCG strain at a MOI = 1 using
the “syringe settle filtrate” (SSF) method (Leisching et al., 2016a)
and allowed 4 h for uptake. The cells were then washed 3 times
with phosphate buffered saline (PBS) to remove any extracellular
M. tb, and incubated for an additional 20 and 92 h in complete
medium (for time points of 24 and 96 h). Uninfected THP-1s served
as the control/uninfected samples. MOIs as well as intracellular
replication p.i was assessed through intracellular CFU counting.
Briefly, after each infection time point, cells were lysed with 0.1%
sterile Triton X-100 where after bacteria were serially diluted and
plated out on 7h11 agar for enumeration.
Gene silencing in THP-1 cells
All three genes were silenced using the FlexiTube siRNA Premix
(Qiagen, Cat. # 1027420) for rapid siRNA transfection (Table 1).
Addition of the siRNA was done after the 4 h uptake period
according to the manufacturer’s instructions and allowed 24 and
96 h for silencing. Silencing was determined through qPCR andversity from ClinicalKey.com by Elsevier on October 21, 
sion. Copyright ©2021. Elsevier Inc. All rights reserved.
G. Leisching et al. / International Journal of Infectious Diseases 80 (2019) S77–S84 S83Western blotting (Supplementary Figure 1) and confirmed for each
silencing experiment.
RNA extraction and quantification
After each infection period, RNA was extracted using the
RNeasy1 Plus Mini Kit (Cat. No. 74134, Qiagen, Limburg,
Netherlands) according to the manufacturer’s instructions. The
extracted RNA was treated with a gDNA eliminator (included in the
kit) to remove all traces of genomic DNA for qPCR. RNA quantity
and quality was assessed using the Agilent 2100 Bioanalyzer.
cDNA synthesis and qPCR
cDNA was synthesized using 0.5 mg RNA using the
Quantitect1 Reverse Transcription Kit (Cat. No. 205311, Qiagen,
Limburg, Netherlands). Prior to cDNA synthesis, a gDNA wipe-
out buffer (included in the kit) was added to the RNA to remove
any remaining genomic DNA. qPCRs were run in 96-well plates
using the LightCycler1 96 system (Roche, Germany) at a reaction
volume of 20 ml. LightCycler1 480 SYBR Green I Master (Cat. No.
04887352001, Roche, Germany) was used to detect amplifica-
tion of cDNA. The amplification procedure entailed 45 cycles of
95 C for 10 s followed by 60 C for 10 s and finally 72 C for 10s.
Gene expression fold-changes were computed using calibrated
relative quantities using the equation N = N0  2Cp (Light-
Cycler196 software, Roche). QuantiTect1 primer assays (Qiagen,
Limburg, Netherlands) were used to assess OAS1 (Cat.#
QT00099134), OAS2 (Cat.# QT01005249) and OAS3 (Cat.#
QT01005277) expression. UBC (Cat.# QT00234430) and G6PD
(Cat. # QT00071596) were used as reference genes for each run. All
qPCRs were done with RNA from three independent experiments,
each with 4 technical replicates. Each biological replicate was run
in triplicate with a positive control (calibrator) and a non-reverse
transcription control in accordance with the MIQE Guidelines
(Bustin et al., 2009).
MTT assay
To evaluate whether silencing of the various genes affected host
cell viability after infection, the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) assay was used (Mosmann,
1983). After each infection time period, 0.01 g/ml MTT was added
to the cells and incubated for 2 h at 37 C at 5% CO2. HCl-
isopropanol-Triton solution (1% HCl in isopropanol, 0.1% Triton X-
100 in a 50:1 ratio) was then added to the cells and gently agitated
for 5 min. The optical density (OD) was determined on a plate
reader (EL-800, Micro-Tek instruments) at a wavelength of 540 nm
and the values expressed as a percentage of the control (uninfected
cells).
Immunofluorescence and analysis
Macrophages were seeded on 14 mm glass cover slips and
infected with either M. bovis BCG, two M. tb strains (hypervirulent
and hypovirulent) or remained uninfected as described above.
Twenty four hours post infection, the cells were heat-fixed at 95 C
for 2 h, followed by permeabilisation with 0.2% Triton X-100 in PBS
for 10 min. Cells were immunostained with OAS1 (Sigma Aldrich
SAB2101669), OAS2 (Invitrogen PA5-37878) or OAS3 (Sigma
Aldrich HPA041253) primary antibodies in 3% BSA for 24 h at
4 C. Cells were then incubated with Texas Red secondary antibody
in 3% BSA in PBS for 90 min and nuclei were counter-stained with
Hoechst for 10 min. Images were acquired on a LSM 780 Elyra S1
Confocal laser-scanning microscope, with a 63X, 1,4NA, oil-
immersion objective at the Central Analytical Facility (StellenboschDownloaded for Anonymous User (n/a) at Stellenbosch Univer
2021. For personal use only. No other uses without permissionUniversity, RSA). Hoechst was viewed with a 360 DAPI Filter
(Intensity 42%, Gain – 500 ms) and Texas Red Marker with a 572
Texas Red filter (Intensity 100%, Gain – 1000 ms).
Quantitative analysis of immunofluorescence was carried out
by analyzing the fluorescent intensity at each pixel across the
images using histogram analysis in Image J (Windows version;
National Institutes of Health) (Collins, 2007). Background signal
was eliminated in the images by using the appropriate thresh-
olding before histogram analysis.
Luminex1
Since OAS expression is interferon-induced during infection, we
sought to determine whether silencing of these genes had any
effect on cytokine or chemokine secretion in THP-1 cells. We used
the Milliplex1 map human cytokine/chemokine magnetic bead
panel kit (Cat.# HCYTOMAG-60K) to simultaneously quantify the
concentrations of TNF-α, IL-1β, IL-10 and MCP-1 in cell culture
supernatants at 24 and 96 h post-infection on the Bioplex 200 (Bio-
Rad) and used the Bioplex Manager 6.1 software for data analysis
(Bio-Rad). Supernatants were collected from three independent
experiments, each with 4 technical replicates which were run in
duplicate.
Statistical analysis
Statistical significance was performed with GraphPad Prism
software. ANOVA was used for comparisons involving 3 or more
groups, with a Bonferroni post-hoc correction applied. All values
are expressed as means  SEM with a p < 0.05 considered as
significant.
Conflict of interest
The authors declare that no conflict of interest exists.
Funding sources
This work was supported by the South African Medical Research
Council and the National Research Foundation of South Africa.
Ethical approval
Ethical approval was not required.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at https://doi.org/10.1016/j.ijid.2019.02.029.
References
Aguilar D, Hanekom M, Mata D, Gey van Pittius NC, van Helden PD, Warren RM, et al.
Mycobacterium tuberculosis strains with the Beijing genotype demonstrate
variability in virulence associated with transmission. Tuberculosis
2010;90:319–25.
Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, et al. An interferon-
inducible neutrophil-driven blood transcriptional signature in human tuber-
culosis. Nature 2010;466:973–7.
Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE
guidelines: minimum information for publication of quantitative real-time PCR
experiments. Clin Chem 2009;55:611–22.
Castelli J, Wood KA, Youle RJ. The 2–5A system in viral infection and apoptosis.
Biomed Pharmacother 1998a;52:386–90.
Castelli JC, Hassel BA, Maran A, Paranjape J, Hewitt JA, Li X-l, et al. The role of 20–50
oligoadenylate-activated ribonuclease L in apoptosis. Cell Death Differ
1998b;5:.
Chen Q, Sun L, Chen ZJ. Regulation and function of the cGAS-STING pathway of
cytosolic DNA sensing. Nat Immunol 2016;17:1142–9.
Collins TJ. ImageJ for microscopy. Biotechniques 2007;43:25–30.sity from ClinicalKey.com by Elsevier on October 21, 
. Copyright ©2021. Elsevier Inc. All rights reserved.
S84 G. Leisching et al. / International Journal of Infectious Diseases 80 (2019) S77–S84D'andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin
10 (IL-10) inhibits human lymphocyte interferon gamma-production by
suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory
cells. J Exp Med 1993;178:1041–8.
Decker T, Müller M, Stockinger S. The yin and yang of type I interferon activity in
bacterial infection. Nat Rev Immunol 2005;5:675–87.
Domingo-Gil E, González JM, Esteban M. Identification of cellular genes induced in
human cells after activation of the OAS/RNaseL pathway by vaccinia virus
recombinants expressing these antiviral enzymes. J Interferon Cytokine Res
2010;30:171–88.
Ezelle HJ, Malathi K, Hassel BA. The roles of RNase-L in antimicrobial immunity and
the cytoskeleton-associated innate response. Int J Mol Sci 2016;17:74.
Ishikawa H, Ma Z, Barber GN. STING regulates intracellular DNA-mediated, type I
interferon-dependent innate immunity. Nature 2009;461:788–92.
Justesen J, Hartmann R, Kjeldgaard N. Gene structure and function of the 20–50-
oligoadenylate synthetase family. Cell Mol Life Sci 2000;57:1593–612.
Kleinnijenhuis J, Quintin J, Preijers F, Benn CS, Joosten LA, Jacobs C, et al. Long-lasting
effects of BCG vaccination on both heterologous Th1/Th17 responses and innate
trained immunity. J Innate Immun 2014;6:152–8.
Kristiansen H, Scherer CA, McVean M, Iadonato SP, Vends S, Thavachelvam K, et al.
Extracellular 20–50 oligoadenylate synthetase stimulates RNase L-independent
antiviral activity: a novel mechanism of virus-induced innate immunity. J Virol
2010;84:11898–904.
Kwon Y-C, Kang J-I, Hwang SB, Ahn B-Y. The ribonuclease L-dependent antiviral
roles of human 20 ,50-oligoadenylate synthetase family members against
hepatitis C virus. FEBS Lett 2013;587:156–64.
Leisching G, Pietersen R-D, Mpongoshe V, van Heerden C, van Helden P, Wiid I, et al.
The host response to a clinical MDR mycobacterial strain cultured in a
detergent-free environment: a global transcriptomics approach. PLoS One
2016a;11:e0153079.
Leisching G, Pietersen R-D, Wiid I, Baker B. Virulence biochemistry, morphology and
host-interacting properties of detergent-free cultured mycobacteria: an update.
Tuberculosis 2016b;100:53–60.
Leisching G, Wiid I, Baker B. OAS1, 2 and 3: significance during active TB?. J Infect Dis
2018;jiy084.
Li Y, Banerjee S, Wang Y, Goldstein SA, Dong B, Gaughan C, et al. Activation of RNase L
is dependent on OAS3 expression during infection with diverse human viruses.
Proc Natl Acad Sci 2016;113:2241–6.
Lin R-J, Yu H-P, Chang B-L, Tang W-C, Liao C-L, Lin Y-L. Distinct antiviral roles for
human 20 ,50-oligoadenylate synthetase family members against dengue virus
infection. J Immunol 2009;183:8035–43.
Lohöfener J, Steinke N, Kay-Fedorov P, Baruch P, Nikulin A, Tishchenko S, et al. The
Activation mechanism of 20-50-oligoadenylate synthetase gives new insights
into OAS/cGAS triggers of innate immunity. Structure 2015;23:851–62.Downloaded for Anonymous User (n/a) at Stellenbosch Uni
2021. For personal use only. No other uses without permisMaertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, Black G, et al. Human gene
expression profiles of susceptibility and resistance in tuberculosis. Genes
Immun 2011;12:15.
Maertzdorf J, Weiner J, Mollenkopf H-J, Network T, Bauer T, Prasse A, et al. Common
patterns and disease-related signatures in tuberculosis and sarcoidosis. Proc
Natl Acad Sci 2012;109:7853–8.
Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, et al. Virulence of a
Mycobacterium tuberculosis clinical isolate in mice is determined by failure to
induce Th1 type immunity and is associated with induction of IFN-alpha/beta.
Proc Natl Acad Sci U S A 2001;98:5752–7.
Manzanillo Paolo S, Shiloh Michael U, Portnoy Daniel A, Cox Jeffery S.
Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance
pathway within macrophages. Cell Host Microbe 2012;11:469–80.
McNab F, Mayer-Barber K, Sher A, Wack A, O'garra A. Type I interferons in infectious
disease. Nat Rev Immunol 2015;15:87–103.
Melchjorsen J, Kristiansen H, Christiansen R, Rintahaka J, Matikainen S, Paludan SR,
et al. Differential regulation of the OASL and OAS1 genes in response to viral
infections. J Interferon Cytokine Res 2009;29:199–208.
Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the
interleukin-10 receptor. Ann Rev Immunol 2001;19:683–765.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application
to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
Ottenhoff THM, Dass RH, Yang N, Zhang MM, Wong HEE, Sahiratmadja E, et al.
Genome-wide expression profiling identifies type 1 interferon response
pathways in active tuberculosis. PLoS One 2012;7:e45839.
Tone M, Powell MJ, Tone Y, Thompson SA, Waldmann H. IL-10 gene expression
is controlled by the transcription factors Sp1 and Sp3. J Immunol
2000;165:286–91.
Vance RE, Isberg RR, Portnoy DA. Patterns of pathogenesis: discrimination of
pathogenic and nonpathogenic microbes by the innate immune system. Cell
Host Microbe 2009;6:10–21.
Wang B, Zhao X-P, Fan Y-C, Zhang J-J, Zhao J, Wang K. IL-17A but not IL-22 suppresses
the replication of hepatitis B virus mediated by over-expression of MxA and OAS
mRNA in the HepG2. 2.15 cell line. Antivir Res 2013;97:285–92.
Yao YL, Yu D, Xu L, Fan Y, Wu Y, Gu T, et al. Molecular characterization of the 20,50-
oligoadenylate synthetase family in the Chinese tree shrew (Tupaia belangeri
chinensis). Cytokine 2018;.
Zhao L, Jha BK, Wu A, Elliott R, Ziebuhr J, Gorbalenya AE, et al. Antagonism of the
interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is
required for virus replication and liver pathology. Cell Host Microbe
2012;11:607–16.versity from ClinicalKey.com by Elsevier on October 21, 
sion. Copyright ©2021. Elsevier Inc. All rights reserved.
